Menveo, Pulver und Lösung (Durchstechflaschen)

7680625020022 CH-62502 Pulver
Menveo, Pulver und Lösung (Durchstechflaschen)
Menveo, Pulver und Lösung (Durchstechflaschen)
Menveo, Pulver und Lösung (Durchstechflaschen)
1 / 3
google

Article details

Package size
5
Selling units
unbekannt
Measure
Kombipackung(en)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
I
10.0 UG Substance Wirkstoff (Principe actif)
II
5.0 UG Substance Wirkstoff (Principe actif)
II
- Substance WIZUS
I
- Substance WIZUS
II
5.0 UG Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
II
- Substance WIZUS
I
0.098 MG Substance HBESI
I
- Substance HNIDK
II
5.0 UG Substance Wirkstoff (Principe actif)
II
- Substance WIZUS
II
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
II
1.885 MG Substance HBESI

Reimbursement information

Public price
CHF 37.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
62502
Drug name
Menveo, Pulver und Lösung (Durchstechflaschen)
Galenic form
SUPA
ATC Code
J07AH08
Authorization status
Z
Dispensing category
B
First authorization
30/11/2011
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Meningokokken-Meningitis der Serogruppen A, C, W135 und Y

Package details

Description (FR)
MENVEO subst sèche c solv flac 5 pce
Description (DE)
MENVEO Trockensub c Solv Durchstf 5 Stk
Market launch
30/11/2011
Narcotic (BTM)
No

Other package sizes (1)

MENVEO subst sèche c solv flac
1 KOMB
GTIN: 7680625020015
View